ダウンロード数: 267
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
68_5_155.pdf | 1.9 MB | Adobe PDF | 見る/開く |
タイトル: | 局所進行直腸癌に対してロボット支援骨盤内臓全摘除術および体腔内回腸導管造設術を施行した2例 |
その他のタイトル: | Two Cases of Robot-Assisted Total Pelvic Exenteration and Intracorporeal Ileal Conduit for Locally Advanced Rectal Cancer |
著者: | 佐々木, 雄太郎 安宅, 真利花 多田, 航生 中西, 亮太 橋本, 啓佑 吉岡, 拓哉 大豆本, 圭 尾崎, 啓介 上野, 恵輝 津田, 恵 楠原, 義人 布川, 朋也 山本, 恭代 山口, 邦久 高橋, 正幸 金山, 博臣 柏原, 秀也 徳永, 卓哉 |
著者名の別形: | SASAKI, Yutaro ATAGI, Marika TADA, Koki NAKANISHI, Ryota HASHIMOTO, Keisuke YOSHIOKA, Takuya DAIZUMOTO, Kei OZAKI, Keisuke UENO, Yoshiteru TSUDA, Megumi KUSUHARA, Yoshito FUKAWA, Tomoya YAMAMOTO, Yasuyo YAMAGUCHI, Kunihisa TAKAHASHI, Masayuki KANAYAMA, Hiroomi KASHIHARA, Hideya TOKUNAGA, Takuya |
キーワード: | Robot-assisted total pelvic exenteration Intracorporeal urinary diversion Intracorporeal ileal conduit |
発行日: | 31-May-2022 |
出版者: | 泌尿器科紀要刊行会 |
誌名: | 泌尿器科紀要 |
巻: | 68 |
号: | 5 |
開始ページ: | 155 |
終了ページ: | 159 |
抄録: | We describe two cases of locally advanced rectal cancer (LARC) treated with robot-assisted total pelvic exenteration (Ra-TPE) and intracorporeal ileal conduit (ICIC). The first case was in a 71-year-old man with LARC (RbP, T4bN2bM0, cStage IIIc). He was started on bevacizumab+S-1/oxaliplatin therapy in July 2019. In April 2020, he developed Fournier's gangrene due to subcutaneous penetration of rectal cancer. Emergency drainage and colostomy were performed simultaneously, and a percutaneous vesical fistula was created. In May 2020, Ra-TPE and ICIC were performed. Histopathological analysis revealed moderately differentiated tubular adenocarcinoma (ypT3N0, RM0). At postoperative 9 months, thoracoscopic right upper lobectomy was performed for a right metastatic lung tumor. At present, ie, at postoperative 12 months, the patient has been free of recurrence and metastasis, with a carcinoembryonic antigen (CEA) level of 1.4 ng/ml and carcinoma antigen (CA) 19-9 level of 11 U/ml. The second case was in a 61-year-old man with fistula-associated anal cancer (PRb, T4N3M1b, cStage IVb). In April 2019, he was started on FOLFOXIRI+cetuximab therapy. In August 2020, Ra-TPE, ICIC, and transperineal total mesenteric excision were performed. Histopathological analysis revealed adenocarcinoma (ypT4N0, RM0). At postoperative 11 months, thoracoscopic left lower lobectomy was performed for a left metastatic lung tumor. At present, ie, at postoperative 12 months, the patient remains free of recurrence and metastasis, with a CEA level of 7.3 ng/ml and CA19-9 level of 12 U/ml. Ra-TPE, which allows transperineal removal of a specimen, can be performed as a minimally invasive surgery in combination with ICIC. |
著作権等: | 許諾条件により本文は2023/06/01に公開 |
DOI: | 10.14989/ActaUrolJap_68_5_155 |
URI: | http://hdl.handle.net/2433/274591 |
PubMed ID: | 35748234 |
出現コレクション: | Vol.68 No.5 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。